Replies to post #191375 on Biotech Values

[DewDiligence]

ENDP selling $2.0B* of stock on unspecified terms to pay for a portion of the Par Pharmaceutical acquisition:

http://finance.yahoo.com/news/endo-international-plc-announces-proposed-213500840.html

*Assuming exercise of underwriter’s option.